Mag. Lukas Kadawy
Lukas served as Chief Financial Officer at Apeiron Biologics AG from 2005 to 2015. He has since co-founded other biotech and diagnostic companies and started his own consultancy business to support scientific founders.
In his corporate roles, he helped manage the growth of companies from start-up to grown-up stages with 30+ employees, with projects ranging from early-stage research projects, across mid- to late-stage clinical programs all the way through to marketing authorization (Qarziba® for the treatment of neuroblastoma).
He handled various equity and debt-based financing rounds, in- and out-licensing agreements with Big Pharma, spin-outs, and his responsibilities included legal affairs, business development, administration, HR and investor relations.